Filed Feb. 7, 2020

Serial No. 88788969

Registered Dec. 13, 2022

Registration No. 6,925,355

Class Pharmaceutical preparations, namely, compounds for use in treating addiction, substance abuse and dependence, diseases and disorders of the central nervous system, cancer, reward disorders, psychiatric and neurodegenerative diseases and disorders in the nature of schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, and bipolar disorder; pharmaceutical preparations for use in treating cardiovascular diseases and metabolic diseases; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidaemia; Pharmaceutical preparations, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; pharmaceutical preparations in the nature of compounds, namely, small molecules and chemical compounds for use in opioid modulation for treating opioid use disorders; 005; 006; 018; 044; 046; 051; 052; 100; 101; 102; 100; 101; 102; 100; 101; 100; 101

Case Type Trademark Service mark